miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
by: Patricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, Manuela Moreno, Víctor Sapena, Juan M. Praena-Fernández, Francisco J. Castell, Juan Manuel Falcón-Pérez, María Reig, Bernhard Brüne, Miguel A. Gómez-Bravo, Álvaro Giráldez, Jordi Bruix, María T. Ferrer, Jordi Muntané
Format: | Article |
---|---|
Published: | MDPI AG 2022-08-01 |
Tab content not available
Tab content not available
Tab content not available
Tab content not available
Tab content not available